Skip to the content
info@appilitherapeutics.com
Get in Touch
Home
Pipeline
Strategy
About Us
Investors
News & Events
Contact
Menu
Home
Pipeline
Strategy
About Us
Investors
News & Events
Contact
NEWS
Archives 2016-2021
News
Highlights
News
2024
News
2023
News
2022
Archives
2016-2021
Media
Contact
Media And
Events
News
Highlights
News
2024
News
2023
News
2022
Archives
2016-2021
Media
Contact
Media And
Events
Archives 2021
Archives 2020
Archives 2019
Archives 2018
Archives 2017
Archives 2016
Archives 2021
Archives 2020
Archives 2019
Archives 2018
Archives 2017
Archives 2016
December 23, 2021
Appili Therapeutics – Press Release Correction
Read More
December 22, 2021
Appili Therapeutics Announces Update to Funding Agreement with The Lind Partners
Read More
November 19, 2021
Appili Therapeutics Announces Positive One Year Challenge Results from Preclinical Study Evaluating Biodefense Vaccine Candidate ATI-1701 and Change to Board of Directors
Read More
November 12, 2021
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2022 and Change of Chief Financial Officer
Read More
November 12, 2021
Appili Therapeutics Provides Update on Phase 3 PRESECO Clinical Trial Evaluating Avigan®/Reeqonus™
Read More
October 14, 2021
Appili Therapeutics Announces Closing of Public Offering of $7,000,220
Read More
